Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies 2020 | LUMEVOQ: gene therapy for Leber hereditary optic neuropathy

Magali Taiel • 1 Sep 2020
Advanced Therapies 2020
Leber Hereditary Optic Neuropathy Rare Diseases

Magali Taiel, MD, of GenSight Biologics, Paris, France, discusses LUMEVOQ gene therapy for patients with Leber hereditary optic neuropathy, a mitochondrial inherited form of vision loss. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Magali Taiel

2:40
LUMEVOQ gene therapy for LHON
Magali Taiel • 6 Oct 2021
4:19
RESCUE & REVERSE: long-term follow ups of LUMEVOQ gene therapy
Magali Taiel • 1 Sep 2020

Related Videos

1:38
Overcoming manufacturing issues in gene therapies for rare diseases
John Maslowski • 27 Jan 2022
2:12
Innovations in treating rare diseases with gene therapies
John Maslowski • 27 Jan 2022
7:04
Applications of single-cell multi-omics analysis
Yan Zhang • 21 Oct 2021
2:38
Expanding the repertoire of CRISPR-based genomic editors
Devyn Smith • 29 Oct 2021
The content of VJRegenMed is intended for healthcare professionals